SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $576,000 | +12.1% | 52,400 | 0.0% | 0.01% | +16.7% |
| Q1 2017 | $514,000 | -9.2% | 52,400 | 0.0% | 0.01% | -14.3% |
| Q4 2016 | $566,000 | +31.0% | 52,400 | +24.5% | 0.01% | +16.7% |
| Q3 2016 | $432,000 | -22.4% | 42,100 | -1.3% | 0.01% | -33.3% |
| Q2 2016 | $557,000 | -8.2% | 42,650 | -22.7% | 0.01% | -10.0% |
| Q1 2016 | $607,000 | -70.9% | 55,150 | -75.7% | 0.01% | -74.4% |
| Q4 2015 | $2,088,000 | +43.1% | 226,950 | +7.9% | 0.04% | +25.8% |
| Q3 2015 | $1,459,000 | -10.9% | 210,250 | +26.2% | 0.03% | -3.1% |
| Q2 2015 | $1,637,000 | +10.8% | 166,650 | 0.0% | 0.03% | +3.2% |
| Q1 2015 | $1,477,000 | +1.2% | 166,650 | 0.0% | 0.03% | -6.1% |
| Q4 2014 | $1,460,000 | +27.2% | 166,650 | 0.0% | 0.03% | +13.8% |
| Q3 2014 | $1,148,000 | +30.9% | 166,650 | 0.0% | 0.03% | +26.1% |
| Q2 2014 | $877,000 | +19.2% | 166,650 | +3.0% | 0.02% | +9.5% |
| Q1 2014 | $736,000 | +30.7% | 161,750 | +44.7% | 0.02% | +23.5% |
| Q4 2013 | $563,000 | -0.7% | 111,750 | 0.0% | 0.02% | -10.5% |
| Q3 2013 | $567,000 | – | 111,750 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|